Global Next-Generation Breast Cancer Diagnostic and Screening Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Next-Generation Breast Cancer Diagnostic and Screening Industry Forecast” looks at past sales and reviews total world Next-Generation Breast Cancer Diagnostic and Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected Next-Generation Breast Cancer Diagnostic and Screening sales for 2023 through 2029. With Next-Generation Breast Cancer Diagnostic and Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Breast Cancer Diagnostic and Screening industry.
This Insight Report provides a comprehensive analysis of the global Next-Generation Breast Cancer Diagnostic and Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Next-Generation Breast Cancer Diagnostic and Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next-Generation Breast Cancer Diagnostic and Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Breast Cancer Diagnostic and Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Breast Cancer Diagnostic and Screening.
The global Next-Generation Breast Cancer Diagnostic and Screening market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Next-Generation Breast Cancer Diagnostic and Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Next-Generation Breast Cancer Diagnostic and Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Next-Generation Breast Cancer Diagnostic and Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Next-Generation Breast Cancer Diagnostic and Screening players cover Abbott Laboratories, Agendia, Agilent Technologies, Ambry Genetics, Biocept, Biotheranostics, Centogene, Danaher Corporation and EXACT Sciences Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Breast Cancer Diagnostic and Screening market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Next-Generation Breast Cancer Diagnostic and Screening Industry Forecast” looks at past sales and reviews total world Next-Generation Breast Cancer Diagnostic and Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected Next-Generation Breast Cancer Diagnostic and Screening sales for 2023 through 2029. With Next-Generation Breast Cancer Diagnostic and Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Breast Cancer Diagnostic and Screening industry.
This Insight Report provides a comprehensive analysis of the global Next-Generation Breast Cancer Diagnostic and Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Next-Generation Breast Cancer Diagnostic and Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next-Generation Breast Cancer Diagnostic and Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Breast Cancer Diagnostic and Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Breast Cancer Diagnostic and Screening.
The global Next-Generation Breast Cancer Diagnostic and Screening market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Next-Generation Breast Cancer Diagnostic and Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Next-Generation Breast Cancer Diagnostic and Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Next-Generation Breast Cancer Diagnostic and Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Next-Generation Breast Cancer Diagnostic and Screening players cover Abbott Laboratories, Agendia, Agilent Technologies, Ambry Genetics, Biocept, Biotheranostics, Centogene, Danaher Corporation and EXACT Sciences Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Breast Cancer Diagnostic and Screening market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Real-Time PCR (q-PCR)
- Immunohistochemistry (IHC)
- Next-Generation Sequencing (NGS)
- Fluorescent In-Situ Hybridization (FISH)
- Hospital-associated Labs
- Cancer Research Institutes
- Diagnostic Centers
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Agendia
- Agilent Technologies
- Ambry Genetics
- Biocept
- Biotheranostics
- Centogene
- Danaher Corporation
- EXACT Sciences Corporation
- Roche Holding AG
- Fulgent Genetics
- Illumina
- Invitae
- Lucence Diagnostics Pte Ltd
- Myriad Genetics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size 2018-2029
2.1.2 Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Next-Generation Breast Cancer Diagnostic and Screening Segment by Type
2.2.1 Real-Time PCR (q-PCR)
2.2.2 Immunohistochemistry (IHC)
2.2.3 Next-Generation Sequencing (NGS)
2.2.4 Fluorescent In-Situ Hybridization (FISH)
2.3 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type
2.3.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
2.4 Next-Generation Breast Cancer Diagnostic and Screening Segment by Application
2.4.1 Hospital-associated Labs
2.4.2 Cancer Research Institutes
2.4.3 Diagnostic Centers
2.5 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application
2.5.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
3 NEXT-GENERATION BREAST CANCER DIAGNOSTIC AND SCREENING MARKET SIZE BY PLAYER
3.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Players
3.1.1 Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Players (2018-2023)
3.1.2 Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Players (2018-2023)
3.2 Global Next-Generation Breast Cancer Diagnostic and Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEXT-GENERATION BREAST CANCER DIAGNOSTIC AND SCREENING BY REGIONS
4.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Regions (2018-2023)
4.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2018-2023)
4.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2018-2023)
4.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2018-2023)
4.5 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2018-2023)
5.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023)
5.3 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2018-2023)
6.2 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023)
6.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Next-Generation Breast Cancer Diagnostic and Screening by Country (2018-2023)
7.2 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023)
7.3 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening by Region (2018-2023)
8.2 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023)
8.3 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC AND SCREENING MARKET FORECAST
10.1 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Regions (2024-2029)
10.1.1 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Regions (2024-2029)
10.1.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Forecast
10.1.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Forecast
10.1.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Forecast
10.1.5 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Forecast
10.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Forecast by Country (2024-2029)
10.2.1 United States Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.2.2 Canada Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.2.3 Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.2.4 Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Forecast by Region (2024-2029)
10.3.1 China Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.3.2 Japan Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.3.3 Korea Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.3.4 Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.3.5 India Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.3.6 Australia Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Forecast by Country (2024-2029)
10.4.1 Germany Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.4.2 France Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.4.3 UK Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.4.4 Italy Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.4.5 Russia Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.5 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Forecast by Region (2024-2029)
10.5.1 Egypt Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.5.2 South Africa Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.5.3 Israel Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.5.4 Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.5.5 GCC Countries Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.6 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Type (2024-2029)
10.7 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.1.3 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Agendia
11.2.1 Agendia Company Information
11.2.2 Agendia Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.2.3 Agendia Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Agendia Main Business Overview
11.2.5 Agendia Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.3.3 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 Ambry Genetics
11.4.1 Ambry Genetics Company Information
11.4.2 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.4.3 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Ambry Genetics Main Business Overview
11.4.5 Ambry Genetics Latest Developments
11.5 Biocept
11.5.1 Biocept Company Information
11.5.2 Biocept Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.5.3 Biocept Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Biocept Main Business Overview
11.5.5 Biocept Latest Developments
11.6 Biotheranostics
11.6.1 Biotheranostics Company Information
11.6.2 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.6.3 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Biotheranostics Main Business Overview
11.6.5 Biotheranostics Latest Developments
11.7 Centogene
11.7.1 Centogene Company Information
11.7.2 Centogene Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.7.3 Centogene Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Centogene Main Business Overview
11.7.5 Centogene Latest Developments
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Information
11.8.2 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.8.3 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Danaher Corporation Main Business Overview
11.8.5 Danaher Corporation Latest Developments
11.9 EXACT Sciences Corporation
11.9.1 EXACT Sciences Corporation Company Information
11.9.2 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.9.3 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 EXACT Sciences Corporation Main Business Overview
11.9.5 EXACT Sciences Corporation Latest Developments
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Information
11.10.2 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.10.3 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Roche Holding AG Main Business Overview
11.10.5 Roche Holding AG Latest Developments
11.11 Fulgent Genetics
11.11.1 Fulgent Genetics Company Information
11.11.2 Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.11.3 Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Fulgent Genetics Main Business Overview
11.11.5 Fulgent Genetics Latest Developments
11.12 Illumina
11.12.1 Illumina Company Information
11.12.2 Illumina Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.12.3 Illumina Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Illumina Main Business Overview
11.12.5 Illumina Latest Developments
11.13 Invitae
11.13.1 Invitae Company Information
11.13.2 Invitae Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.13.3 Invitae Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Invitae Main Business Overview
11.13.5 Invitae Latest Developments
11.14 Lucence Diagnostics Pte Ltd
11.14.1 Lucence Diagnostics Pte Ltd Company Information
11.14.2 Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.14.3 Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Lucence Diagnostics Pte Ltd Main Business Overview
11.14.5 Lucence Diagnostics Pte Ltd Latest Developments
11.15 Myriad Genetics
11.15.1 Myriad Genetics Company Information
11.15.2 Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.15.3 Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Myriad Genetics Main Business Overview
11.15.5 Myriad Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size 2018-2029
2.1.2 Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Next-Generation Breast Cancer Diagnostic and Screening Segment by Type
2.2.1 Real-Time PCR (q-PCR)
2.2.2 Immunohistochemistry (IHC)
2.2.3 Next-Generation Sequencing (NGS)
2.2.4 Fluorescent In-Situ Hybridization (FISH)
2.3 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type
2.3.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
2.4 Next-Generation Breast Cancer Diagnostic and Screening Segment by Application
2.4.1 Hospital-associated Labs
2.4.2 Cancer Research Institutes
2.4.3 Diagnostic Centers
2.5 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application
2.5.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
3 NEXT-GENERATION BREAST CANCER DIAGNOSTIC AND SCREENING MARKET SIZE BY PLAYER
3.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Players
3.1.1 Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Players (2018-2023)
3.1.2 Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Players (2018-2023)
3.2 Global Next-Generation Breast Cancer Diagnostic and Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEXT-GENERATION BREAST CANCER DIAGNOSTIC AND SCREENING BY REGIONS
4.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Regions (2018-2023)
4.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2018-2023)
4.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2018-2023)
4.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2018-2023)
4.5 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2018-2023)
5.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023)
5.3 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2018-2023)
6.2 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023)
6.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Next-Generation Breast Cancer Diagnostic and Screening by Country (2018-2023)
7.2 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023)
7.3 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening by Region (2018-2023)
8.2 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023)
8.3 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC AND SCREENING MARKET FORECAST
10.1 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Regions (2024-2029)
10.1.1 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Regions (2024-2029)
10.1.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Forecast
10.1.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Forecast
10.1.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Forecast
10.1.5 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Forecast
10.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Forecast by Country (2024-2029)
10.2.1 United States Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.2.2 Canada Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.2.3 Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.2.4 Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Forecast by Region (2024-2029)
10.3.1 China Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.3.2 Japan Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.3.3 Korea Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.3.4 Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.3.5 India Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.3.6 Australia Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Forecast by Country (2024-2029)
10.4.1 Germany Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.4.2 France Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.4.3 UK Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.4.4 Italy Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.4.5 Russia Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.5 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Forecast by Region (2024-2029)
10.5.1 Egypt Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.5.2 South Africa Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.5.3 Israel Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.5.4 Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.5.5 GCC Countries Next-Generation Breast Cancer Diagnostic and Screening Market Forecast
10.6 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Type (2024-2029)
10.7 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.1.3 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Agendia
11.2.1 Agendia Company Information
11.2.2 Agendia Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.2.3 Agendia Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Agendia Main Business Overview
11.2.5 Agendia Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.3.3 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 Ambry Genetics
11.4.1 Ambry Genetics Company Information
11.4.2 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.4.3 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Ambry Genetics Main Business Overview
11.4.5 Ambry Genetics Latest Developments
11.5 Biocept
11.5.1 Biocept Company Information
11.5.2 Biocept Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.5.3 Biocept Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Biocept Main Business Overview
11.5.5 Biocept Latest Developments
11.6 Biotheranostics
11.6.1 Biotheranostics Company Information
11.6.2 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.6.3 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Biotheranostics Main Business Overview
11.6.5 Biotheranostics Latest Developments
11.7 Centogene
11.7.1 Centogene Company Information
11.7.2 Centogene Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.7.3 Centogene Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Centogene Main Business Overview
11.7.5 Centogene Latest Developments
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Information
11.8.2 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.8.3 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Danaher Corporation Main Business Overview
11.8.5 Danaher Corporation Latest Developments
11.9 EXACT Sciences Corporation
11.9.1 EXACT Sciences Corporation Company Information
11.9.2 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.9.3 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 EXACT Sciences Corporation Main Business Overview
11.9.5 EXACT Sciences Corporation Latest Developments
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Information
11.10.2 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.10.3 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Roche Holding AG Main Business Overview
11.10.5 Roche Holding AG Latest Developments
11.11 Fulgent Genetics
11.11.1 Fulgent Genetics Company Information
11.11.2 Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.11.3 Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Fulgent Genetics Main Business Overview
11.11.5 Fulgent Genetics Latest Developments
11.12 Illumina
11.12.1 Illumina Company Information
11.12.2 Illumina Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.12.3 Illumina Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Illumina Main Business Overview
11.12.5 Illumina Latest Developments
11.13 Invitae
11.13.1 Invitae Company Information
11.13.2 Invitae Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.13.3 Invitae Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Invitae Main Business Overview
11.13.5 Invitae Latest Developments
11.14 Lucence Diagnostics Pte Ltd
11.14.1 Lucence Diagnostics Pte Ltd Company Information
11.14.2 Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.14.3 Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Lucence Diagnostics Pte Ltd Main Business Overview
11.14.5 Lucence Diagnostics Pte Ltd Latest Developments
11.15 Myriad Genetics
11.15.1 Myriad Genetics Company Information
11.15.2 Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
11.15.3 Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Myriad Genetics Main Business Overview
11.15.5 Myriad Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Real-Time PCR (q-PCR)
Table 3. Major Players of Immunohistochemistry (IHC)
Table 4. Major Players of Next-Generation Sequencing (NGS)
Table 5. Major Players of Fluorescent In-Situ Hybridization (FISH)
Table 6. Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Table 9. Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Table 12. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Player (2018-2023)
Table 14. Next-Generation Breast Cancer Diagnostic and Screening Key Players Head office and Products Offered
Table 15. Next-Generation Breast Cancer Diagnostic and Screening Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Regions (2018-2023)
Table 20. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Country (2018-2023)
Table 24. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Table 26. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Table 28. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region (2018-2023)
Table 30. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Table 32. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Table 34. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Country (2018-2023)
Table 36. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Table 38. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Next-Generation Breast Cancer Diagnostic and Screening
Table 47. Key Market Challenges & Risks of Next-Generation Breast Cancer Diagnostic and Screening
Table 48. Key Industry Trends of Next-Generation Breast Cancer Diagnostic and Screening
Table 49. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 54. Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 55. Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Agendia Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 59. Agendia Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 60. Agendia Main Business
Table 61. Agendia Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Agendia Latest Developments
Table 63. Agilent Technologies Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 64. Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 65. Agilent Technologies Main Business
Table 66. Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Agilent Technologies Latest Developments
Table 68. Ambry Genetics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 69. Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 70. Ambry Genetics Main Business
Table 71. Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Ambry Genetics Latest Developments
Table 73. Biocept Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 74. Biocept Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 75. Biocept Main Business
Table 76. Biocept Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Biocept Latest Developments
Table 78. Biotheranostics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 79. Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 80. Biotheranostics Main Business
Table 81. Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Biotheranostics Latest Developments
Table 83. Centogene Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 84. Centogene Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 85. Centogene Main Business
Table 86. Centogene Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Centogene Latest Developments
Table 88. Danaher Corporation Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 89. Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 90. Danaher Corporation Main Business
Table 91. Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Danaher Corporation Latest Developments
Table 93. EXACT Sciences Corporation Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 94. EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 95. EXACT Sciences Corporation Main Business
Table 96. EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. EXACT Sciences Corporation Latest Developments
Table 98. Roche Holding AG Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 99. Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 100. Roche Holding AG Main Business
Table 101. Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Roche Holding AG Latest Developments
Table 103. Fulgent Genetics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 104. Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 105. Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Fulgent Genetics Main Business
Table 107. Fulgent Genetics Latest Developments
Table 108. Illumina Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 109. Illumina Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 110. Illumina Main Business
Table 111. Illumina Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Illumina Latest Developments
Table 113. Invitae Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 114. Invitae Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 115. Invitae Main Business
Table 116. Invitae Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Invitae Latest Developments
Table 118. Lucence Diagnostics Pte Ltd Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 119. Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 120. Lucence Diagnostics Pte Ltd Main Business
Table 121. Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Lucence Diagnostics Pte Ltd Latest Developments
Table 123. Myriad Genetics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 124. Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 125. Myriad Genetics Main Business
Table 126. Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Myriad Genetics Latest Developments
Table 1. Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Real-Time PCR (q-PCR)
Table 3. Major Players of Immunohistochemistry (IHC)
Table 4. Major Players of Next-Generation Sequencing (NGS)
Table 5. Major Players of Fluorescent In-Situ Hybridization (FISH)
Table 6. Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Table 9. Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Table 12. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Player (2018-2023)
Table 14. Next-Generation Breast Cancer Diagnostic and Screening Key Players Head office and Products Offered
Table 15. Next-Generation Breast Cancer Diagnostic and Screening Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Regions (2018-2023)
Table 20. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Country (2018-2023)
Table 24. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Table 26. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Table 28. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region (2018-2023)
Table 30. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Table 32. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Table 34. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Country (2018-2023)
Table 36. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Table 38. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Next-Generation Breast Cancer Diagnostic and Screening
Table 47. Key Market Challenges & Risks of Next-Generation Breast Cancer Diagnostic and Screening
Table 48. Key Industry Trends of Next-Generation Breast Cancer Diagnostic and Screening
Table 49. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 54. Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 55. Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Agendia Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 59. Agendia Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 60. Agendia Main Business
Table 61. Agendia Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Agendia Latest Developments
Table 63. Agilent Technologies Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 64. Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 65. Agilent Technologies Main Business
Table 66. Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Agilent Technologies Latest Developments
Table 68. Ambry Genetics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 69. Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 70. Ambry Genetics Main Business
Table 71. Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Ambry Genetics Latest Developments
Table 73. Biocept Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 74. Biocept Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 75. Biocept Main Business
Table 76. Biocept Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Biocept Latest Developments
Table 78. Biotheranostics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 79. Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 80. Biotheranostics Main Business
Table 81. Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Biotheranostics Latest Developments
Table 83. Centogene Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 84. Centogene Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 85. Centogene Main Business
Table 86. Centogene Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Centogene Latest Developments
Table 88. Danaher Corporation Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 89. Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 90. Danaher Corporation Main Business
Table 91. Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Danaher Corporation Latest Developments
Table 93. EXACT Sciences Corporation Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 94. EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 95. EXACT Sciences Corporation Main Business
Table 96. EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. EXACT Sciences Corporation Latest Developments
Table 98. Roche Holding AG Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 99. Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 100. Roche Holding AG Main Business
Table 101. Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Roche Holding AG Latest Developments
Table 103. Fulgent Genetics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 104. Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 105. Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Fulgent Genetics Main Business
Table 107. Fulgent Genetics Latest Developments
Table 108. Illumina Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 109. Illumina Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 110. Illumina Main Business
Table 111. Illumina Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Illumina Latest Developments
Table 113. Invitae Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 114. Invitae Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 115. Invitae Main Business
Table 116. Invitae Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Invitae Latest Developments
Table 118. Lucence Diagnostics Pte Ltd Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 119. Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 120. Lucence Diagnostics Pte Ltd Main Business
Table 121. Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Lucence Diagnostics Pte Ltd Latest Developments
Table 123. Myriad Genetics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors
Table 124. Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered
Table 125. Myriad Genetics Main Business
Table 126. Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Myriad Genetics Latest Developments
LIST OF FIGURES
Figure 1. Next-Generation Breast Cancer Diagnostic and Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Next-Generation Breast Cancer Diagnostic and Screening Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Next-Generation Breast Cancer Diagnostic and Screening Sales Market Share by Country/Region (2022)
Figure 8. Next-Generation Breast Cancer Diagnostic and Screening Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type in 2022
Figure 10. Next-Generation Breast Cancer Diagnostic and Screening in Hospital-associated Labs
Figure 11. Global Next-Generation Breast Cancer Diagnostic and Screening Market: Hospital-associated Labs (2018-2023) & ($ Millions)
Figure 12. Next-Generation Breast Cancer Diagnostic and Screening in Cancer Research Institutes
Figure 13. Global Next-Generation Breast Cancer Diagnostic and Screening Market: Cancer Research Institutes (2018-2023) & ($ Millions)
Figure 14. Next-Generation Breast Cancer Diagnostic and Screening in Diagnostic Centers
Figure 15. Global Next-Generation Breast Cancer Diagnostic and Screening Market: Diagnostic Centers (2018-2023) & ($ Millions)
Figure 16. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2022
Figure 17. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Player in 2022
Figure 18. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size 2018-2023 ($ Millions)
Figure 20. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size 2018-2023 ($ Millions)
Figure 21. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size 2018-2023 ($ Millions)
Figure 23. Americas Next-Generation Breast Cancer Diagnostic and Screening Value Market Share by Country in 2022
Figure 24. United States Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region in 2022
Figure 29. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type in 2022
Figure 30. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2022
Figure 31. China Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Country in 2022
Figure 38. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Figure 39. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Figure 40. Germany Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 54. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 55. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 57. United States Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 58. Canada Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 61. China Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 62. Japan Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 63. Korea Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 65. India Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 66. Australia Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 67. Germany Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 68. France Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 69. UK Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 70. Italy Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 71. Russia Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 72. Spain Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 75. Israel Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 78. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Next-Generation Breast Cancer Diagnostic and Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Next-Generation Breast Cancer Diagnostic and Screening Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Next-Generation Breast Cancer Diagnostic and Screening Sales Market Share by Country/Region (2022)
Figure 8. Next-Generation Breast Cancer Diagnostic and Screening Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type in 2022
Figure 10. Next-Generation Breast Cancer Diagnostic and Screening in Hospital-associated Labs
Figure 11. Global Next-Generation Breast Cancer Diagnostic and Screening Market: Hospital-associated Labs (2018-2023) & ($ Millions)
Figure 12. Next-Generation Breast Cancer Diagnostic and Screening in Cancer Research Institutes
Figure 13. Global Next-Generation Breast Cancer Diagnostic and Screening Market: Cancer Research Institutes (2018-2023) & ($ Millions)
Figure 14. Next-Generation Breast Cancer Diagnostic and Screening in Diagnostic Centers
Figure 15. Global Next-Generation Breast Cancer Diagnostic and Screening Market: Diagnostic Centers (2018-2023) & ($ Millions)
Figure 16. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2022
Figure 17. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Player in 2022
Figure 18. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size 2018-2023 ($ Millions)
Figure 20. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size 2018-2023 ($ Millions)
Figure 21. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size 2018-2023 ($ Millions)
Figure 23. Americas Next-Generation Breast Cancer Diagnostic and Screening Value Market Share by Country in 2022
Figure 24. United States Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region in 2022
Figure 29. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type in 2022
Figure 30. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2022
Figure 31. China Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Country in 2022
Figure 38. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Figure 39. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Figure 40. Germany Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 54. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 55. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 57. United States Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 58. Canada Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 61. China Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 62. Japan Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 63. Korea Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 65. India Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 66. Australia Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 67. Germany Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 68. France Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 69. UK Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 70. Italy Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 71. Russia Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 72. Spain Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 75. Israel Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Next-Generation Breast Cancer Diagnostic and Screening Market Size 2024-2029 ($ Millions)
Figure 78. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share Forecast by Application (2024-2029)
